ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Abeloff Directs John Hopkins Oncology Center; Claudia Baquet Named Deputy Secretary In HHS

September 25, 1992

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975

Stop Cancer Changes Leaders, Focus, Sends $1.6M To NCI

August 30, 1991

Lateral Radiation Therapy Results in Regional Control In Advanced Tonsil Cancer

February 28, 2014

NCI Extends PRI’s Fredrick Contract Six Months

September 23, 1994

NCAB Votes To ‘Keep Alive’ Concept For Stage 2 Breast Cancer Fat Trial

February 14, 1986